Skip to main content

3 Reasons to Avoid CAL and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CAL Cover Image

Over the last six months, Caleres’s shares have sunk to $12.26, producing a disappointing 6.8% loss - a stark contrast to the S&P 500’s 7.8% gain. This may have investors wondering how to approach the situation.

Is now the time to buy Caleres, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free.

Why Do We Think Caleres Will Underperform?

Even with the cheaper entry price, we’re swiping left on Caleres for now. Here are three reasons why there are better opportunities than CAL, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, Caleres grew its sales at a weak 3.6% compounded annual growth rate. This fell short of our benchmark for the consumer discretionary sector.

Caleres Quarterly Revenue

2. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

Unfortunately, Caleres’s ROIC has decreased significantly over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Caleres Trailing 12-Month Return On Invested Capital

3. High Debt Levels Increase Risk

As long-term investors, the risk we care about most is the permanent loss of capital, which can happen when a company goes bankrupt or raises money from a disadvantaged position. This is separate from short-term stock price volatility, something we are much less bothered by.

Caleres’s $949.3 million of debt exceeds the $37.74 million of cash on its balance sheet. Furthermore, its 7× net-debt-to-EBITDA ratio (based on its EBITDA of $125.5 million over the last 12 months) shows the company is overleveraged.

Caleres Net Debt Position

At this level of debt, incremental borrowing becomes increasingly expensive and credit agencies could downgrade the company’s rating if profitability falls. Caleres could also be backed into a corner if the market turns unexpectedly – a situation we seek to avoid as investors in high-quality companies.

We hope Caleres can improve its balance sheet and remain cautious until it increases its profitability or pays down its debt.

Final Judgment

We see the value of companies helping consumers, but in the case of Caleres, we’re out. Following the recent decline, the stock trades at 7.1× forward P/E (or $12.26 per share). While this valuation is optically cheap, the potential downside is huge given its shaky fundamentals. There are superior stocks to buy right now. We’d suggest looking at one of our top software and edge computing picks.

Stocks We Like More Than Caleres

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  240.97
+6.85 (2.93%)
AAPL  298.44
+4.13 (1.41%)
AMD  517.50
-2.35 (-0.45%)
BAC  57.72
-0.19 (-0.33%)
GOOG  349.59
+3.51 (1.01%)
META  562.64
+0.44 (0.08%)
MSFT  373.38
-0.56 (-0.15%)
NVDA  200.44
+0.40 (0.20%)
ORCL  159.05
-6.11 (-3.70%)
TSLA  381.04
-0.57 (-0.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.